{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T16:30:44Z","timestamp":1784737844165,"version":"3.55.0"},"reference-count":81,"publisher":"European Respiratory Society (ERS)","issue":"178","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir Rev"],"accepted":{"date-parts":[[2025,9,9]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>\n                    Currently, the only known clinically relevant hereditary risk factor for emphysema is limited to mutations within the\n                    <jats:italic>SERPINA1<\/jats:italic>\n                    gene, encoding alpha-1 antitrypsin. Although several additional rare high-impact variants have been proposed, their role in emphysema pathophysiology is unclear. This review discusses recent cases investigating novel candidate genes that may be Mendelian causes for emphysema development. We also explore potential methods to confirm the causal relation to COPD. Identifying potential new rare high-impact genetic variants may lead to novel therapeutic targets, thus improving the personalised treatment of COPD. Several gene mutations have been implicated in emphysema development, including\n                    <jats:italic>SERPINA1<\/jats:italic>\n                    ,\n                    <jats:italic>SERPINA3<\/jats:italic>\n                    ,\n                    <jats:italic>PTPN6<\/jats:italic>\n                    ,\n                    <jats:italic>TERT<\/jats:italic>\n                    ,\n                    <jats:italic>TR<\/jats:italic>\n                    ,\n                    <jats:italic>NAF1<\/jats:italic>\n                    ,\n                    <jats:italic>BICD1<\/jats:italic>\n                    ,\n                    <jats:italic>ELN<\/jats:italic>\n                    ,\n                    <jats:italic>FBLN<\/jats:italic>\n                    ,\n                    <jats:italic>FLNA<\/jats:italic>\n                    and\n                    <jats:italic>SFTPC<\/jats:italic>\n                    . Mutations of the\n                    <jats:italic>SERPINA1<\/jats:italic>\n                    and\n                    <jats:italic>PTPN6<\/jats:italic>\n                    genes are considered definitive causes of emphysema. Studies have ascertained rare variants in cutis laxa genes (\n                    <jats:italic>ELN, FBLN<\/jats:italic>\n                    and\n                    <jats:italic>FLNA)<\/jats:italic>\n                    , which cause early-onset emphysema in infants and children\n                    <jats:italic>via<\/jats:italic>\n                    defective elastin synthesis. Telomerase pathway genes (\n                    <jats:italic>TERT<\/jats:italic>\n                    ,\n                    <jats:italic>TR<\/jats:italic>\n                    ,\n                    <jats:italic>NAF1<\/jats:italic>\n                    and\n                    <jats:italic>BICD1<\/jats:italic>\n                    ) have also been implicated in increased COPD risk along with another member of the serpin family (\n                    <jats:italic>SERPINA3<\/jats:italic>\n                    ) and\n                    <jats:italic>SFTPC<\/jats:italic>\n                    . These probable mutations for emphysema tend to present later in life. Due to being unconfirmed, they may involve a more complex gene interaction that requires further interrogation with next-generation sequencing and molecular methods, including CRISPR (clustered regularly interspaced short palindromic repeats) screening libraries, whole-exome sequencing or whole-genome sequencing. Although multiple novel mutations have been reported to cause emphysema, further validation is needed. Next-generation sequencing offers a promising method to understand early-onset emphysema and COPD pathogenesis.\n                  <\/jats:p>","DOI":"10.1183\/16000617.0125-2025","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:30:14Z","timestamp":1762939814000},"page":"250125","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Mendelian causes of early-onset emphysema: a review of the current literature"],"prefix":"10.1183","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-7352-3632","authenticated-orcid":false,"given":"Antonia","family":"Karabatic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"van den Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0418-1641","authenticated-orcid":false,"given":"Tom\u00e1s P.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5810-6022","authenticated-orcid":false,"given":"Victor","family":"Guryev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alen","family":"Faiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"2025111201300751000_34.178.250125.1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202107-1663SO"},{"key":"2025111201300751000_34.178.250125.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31222-9"},{"key":"2025111201300751000_34.178.250125.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00054408"},{"key":"2025111201300751000_34.178.250125.4","doi-asserted-by":"crossref","first-page":"1066804","DOI":"10.3389\/fmed.2023.1066804","article-title":"Global, regional, and national burden of chronic respiratory diseases and associated risk factors, 1990\u20132019: results from the Global Burden of Disease Study 2019","volume":"10","author":"Chen","year":"2023","journal-title":"Front Med"},{"key":"2025111201300751000_34.178.250125.5","doi-asserted-by":"crossref","first-page":"e1138","DOI":"10.1016\/S2214-109X(23)00304-2","article-title":"COPD generates substantial cost for health systems","volume":"11","author":"Agarwal","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025111201300751000_34.178.250125.6","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00217-6"},{"key":"2025111201300751000_34.178.250125.7","unstructured":"World Health Organization . Chronic obstructive pulmonary disease (COPD). Date last updated: 9 November 2024. Date last accessed: 13 August 2025. www.who.int\/news-room\/fact-sheets\/detail\/chronic-obstructive-pulmonary-disease-(copd)"},{"key":"2025111201300751000_34.178.250125.8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61382-8"},{"key":"2025111201300751000_34.178.250125.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216037"},{"key":"2025111201300751000_34.178.250125.10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1106955"},{"key":"2025111201300751000_34.178.250125.11","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.2169\/internalmedicine.8077-16","article-title":"Early-onset, severe chronic obstructive pulmonary disease with pulmonary hypertension that was likely induced by toluene exposure","volume":"56","author":"Kobayashi","year":"2017","journal-title":"Intern Med"},{"key":"2025111201300751000_34.178.250125.12","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00018908"},{"key":"2025111201300751000_34.178.250125.13","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.9.1.3"},{"key":"2025111201300751000_34.178.250125.14","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-020-00345-x","article-title":"Progress in the mechanism and targeted drug therapy for COPD","volume":"5","author":"Wang","year":"2020","journal-title":"Signal Transduct Target Ther"},{"key":"2025111201300751000_34.178.250125.15","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2147\/COPD.S1758","article-title":"Identifying targets for COPD treatment through gene expression analyses","volume":"3","author":"Chen","year":"2008","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025111201300751000_34.178.250125.16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2147\/COPD.S10771","article-title":"Improved patient outcome with smoking cessation: when is it too late?","volume":"6","author":"Sin","year":"2011","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025111201300751000_34.178.250125.17","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-016-0132-z"},{"key":"2025111201300751000_34.178.250125.18","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1038\/s41598-023-32485-9","article-title":"Most patients with COPD are unaware of their health threats and are not diagnosed: a national-level study using pulmonary function test","volume":"13","author":"Park","year":"2023","journal-title":"Sci Rep"},{"key":"2025111201300751000_34.178.250125.19","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00002711"},{"key":"2025111201300751000_34.178.250125.20","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1910234"},{"key":"2025111201300751000_34.178.250125.21","doi-asserted-by":"publisher","DOI":"10.3109\/00365516309051324"},{"key":"2025111201300751000_34.178.250125.22","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/jcm12051708","article-title":"SERPINA1 and more? A putative genetic contributor to pulmonary dysfunction in alpha-1 antitrypsin deficiency","volume":"12","author":"Jezela-Stanek","year":"2023","journal-title":"J Clin Med"},{"key":"2025111201300751000_34.178.250125.23","doi-asserted-by":"crossref","first-page":"928","DOI":"10.3949\/ccjm.69.12.928","article-title":"Emphysema in nonsmokers: alpha 1-antitrypsin deficiency and other causes","volume":"69","author":"Lee","year":"2002","journal-title":"Cleve Clin J Med"},{"key":"2025111201300751000_34.178.250125.24","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0172-y"},{"key":"2025111201300751000_34.178.250125.25","doi-asserted-by":"publisher","DOI":"10.1126\/science.181.4094.70"},{"key":"2025111201300751000_34.178.250125.26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S2213-2600(19)30141-9","article-title":"Pitfalls and caveats in \u03b11-antitrypsin deficiency testing: a guide for clinicians","volume":"7","author":"Franciosi","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2025111201300751000_34.178.250125.27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201311-1984OC"},{"key":"2025111201300751000_34.178.250125.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202002-0262OC"},{"key":"2025111201300751000_34.178.250125.29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1164\/rccm.202106-1404OC","article-title":"Alpha-1 antitrypsin MZ heterozygosity is an endotype of chronic obstructive pulmonary disease","volume":"205","author":"Ghosh","year":"2021","journal-title":"Am J Respir Crit Care Med"},{"key":"2025111201300751000_34.178.250125.30","doi-asserted-by":"crossref","first-page":"6351","DOI":"10.3390\/ijms22126351","article-title":"The serpin superfamily and their role in the regulation and dysfunction of serine protease activity in COPD and other chronic lung diseases","volume":"22","author":"Kelly-Robinson","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2025111201300751000_34.178.250125.31","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v1.i5.94"},{"key":"2025111201300751000_34.178.250125.32","doi-asserted-by":"publisher","DOI":"10.2741\/2275"},{"key":"2025111201300751000_34.178.250125.33","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-2600(19)30056-6","article-title":"Early-onset emphysema in a large French-Canadian family: a genetic investigation","volume":"7","author":"Boss\u00e9","year":"2019","journal-title":"Lancet Respir Med"},{"key":"2025111201300751000_34.178.250125.34","doi-asserted-by":"crossref","first-page":"76.10","DOI":"10.4049\/jimmunol.210.Supp.76.10","article-title":"The mutation PTPN6\n               Ala455Thr causing pulmonary emphysema affects B cell populations and causes spontaneous pulmonary tertiary lymphoid tissue formation","volume":"210","author":"Pineault","year":"2023","journal-title":"J Immunol"},{"key":"2025111201300751000_34.178.250125.35","doi-asserted-by":"crossref","first-page":"109189","DOI":"10.1016\/j.abb.2022.109189","article-title":"The regulatory effects of PTPN6 on inflammatory process: reports from mice to men","volume":"721","author":"Kiratikanon","year":"2022","journal-title":"Arch Biochem Biophys"},{"key":"2025111201300751000_34.178.250125.36","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12989-017-0234-0","article-title":"Suppression of PTPN6 exacerbates aluminum oxide nanoparticle-induced COPD-like lesions in mice through activation of STAT pathway","volume":"14","author":"Li","year":"2017","journal-title":"Part Fibre Toxicol"},{"key":"2025111201300751000_34.178.250125.37","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.molmed.2016.09.007","article-title":"Family-specific variants and the limits of human genetics","volume":"22","author":"Shirts","year":"2016","journal-title":"Trends Mol Med"},{"key":"2025111201300751000_34.178.250125.38","first-page":"130","article-title":"AI for science: predicting infectious diseases","volume":"5","author":"Zhao","year":"2024","journal-title":"J Saf Sci Resil"},{"key":"2025111201300751000_34.178.250125.39","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78554"},{"key":"2025111201300751000_34.178.250125.40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201103-0520OC"},{"key":"2025111201300751000_34.178.250125.41","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf7837"},{"key":"2025111201300751000_34.178.250125.42","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201609-718AW"},{"key":"2025111201300751000_34.178.250125.43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2147\/COPD.S35294","article-title":"Updates on the COPD gene list","volume":"7","author":"Bosse","year":"2012","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2025111201300751000_34.178.250125.44","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201004-0541OC"},{"key":"2025111201300751000_34.178.250125.45","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1096\/fba.2018-00055","article-title":"Bicaudal D1 impairs autophagosome maturation in chronic obstructive pulmonary disease","volume":"1","author":"Mercado","year":"2019","journal-title":"FASEB Bioadv"},{"key":"2025111201300751000_34.178.250125.46","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.160.6.9706031"},{"key":"2025111201300751000_34.178.250125.47","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2005-0206OC"},{"key":"2025111201300751000_34.178.250125.48","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/ajmg.a.33300","article-title":"Pulmonary function and emphysema in Williams\u2013Beuren syndrome","volume":"152A","author":"Wan","year":"2010","journal-title":"Am J Med Genet A"},{"key":"2025111201300751000_34.178.250125.49","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2008.099408"},{"key":"2025111201300751000_34.178.250125.50","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1002\/ajmg.a.35464","article-title":"Haploinsufficiency of elastin gene may lead to familial cardiopathy and pulmonary emphysema","volume":"158A","author":"Louw","year":"2012","journal-title":"Am J Med Genet A"},{"key":"2025111201300751000_34.178.250125.51","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.140.9.1135"},{"key":"2025111201300751000_34.178.250125.52","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23758.x"},{"key":"2025111201300751000_34.178.250125.53","doi-asserted-by":"publisher","DOI":"10.1165\/ajrcmb.23.3.3906"},{"key":"2025111201300751000_34.178.250125.54","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00352.2006"},{"key":"2025111201300751000_34.178.250125.55","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-007-7893-1_3"},{"key":"2025111201300751000_34.178.250125.56","doi-asserted-by":"publisher","DOI":"10.1038\/ejhg.2009.22"},{"key":"2025111201300751000_34.178.250125.57","doi-asserted-by":"publisher","DOI":"10.1086\/504304"},{"key":"2025111201300751000_34.178.250125.58","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1016\/j.chest.2020.10.003","article-title":"Filamin A mutations: a new cause of unexplained emphysema in adults?","volume":"159","author":"Valentin","year":"2021","journal-title":"Chest"},{"key":"2025111201300751000_34.178.250125.59","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0331-9"},{"key":"2025111201300751000_34.178.250125.60","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-6-32"},{"key":"2025111201300751000_34.178.250125.61","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/pr.2017.29","article-title":"A novel surfactant protein C mutation resulting in aberrant protein processing and altered subcellular localization causes infantile interstitial lung disease","volume":"81","author":"Hong","year":"2017","journal-title":"Pediatr Res"},{"key":"2025111201300751000_34.178.250125.62","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00386"},{"key":"2025111201300751000_34.178.250125.63","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2010.151407"},{"key":"2025111201300751000_34.178.250125.64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s43586-021-00093-4","article-title":"High-content CRISPR screening","volume":"2","author":"Bock","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"2025111201300751000_34.178.250125.65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12606-7"},{"key":"2025111201300751000_34.178.250125.66","doi-asserted-by":"publisher","DOI":"10.1186\/1479-0556-2-6"},{"key":"2025111201300751000_34.178.250125.67","unstructured":"Costa JR , Bejcek BE , Jullie H , et al. Genome editing using engineered nucleases and their use in genomic screening. In: Markossian S , Grossman A , Baskir H , et al. , eds. The Assay Guidance Manual. Bethesda, National Center for Advancing Translational Sciences, 2017."},{"key":"2025111201300751000_34.178.250125.68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/crispr.2017.0016","article-title":"Impact of genetic variation on CRISPR-Cas targeting","volume":"1","author":"Canver","year":"2018","journal-title":"CRISPR J"},{"key":"2025111201300751000_34.178.250125.69","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0178"},{"key":"2025111201300751000_34.178.250125.70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1126\/sciadv.abo6566","article-title":"CRISPR interference interrogation of COPD GWAS genes reveals the functional significance of desmoplakin in iPSC-derived alveolar epithelial cells","volume":"8","author":"Werder","year":"2022","journal-title":"Sci Adv"},{"key":"2025111201300751000_34.178.250125.71","doi-asserted-by":"crossref","first-page":"e2353514","DOI":"10.1001\/jamanetworkopen.2023.53514","article-title":"Cost-effectiveness of whole-genome vs whole-exome sequencing among children with suspected genetic disorders","volume":"7","author":"Nurchis","year":"2024","journal-title":"JAMA Netw Open"},{"key":"2025111201300751000_34.178.250125.72","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1165\/rcmb.2018-0088OC","article-title":"Whole-genome sequencing in severe chronic obstructive pulmonary disease","volume":"59","author":"Prokopenko","year":"2018","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2025111201300751000_34.178.250125.73","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-022-01162-2"},{"key":"2025111201300751000_34.178.250125.74","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.chest.2024.09.038","article-title":"Editing approaches to treat alpha-1 antitrypsin deficiency (AATD)","volume":"167","author":"Erion","year":"2025","journal-title":"Chest"},{"key":"2025111201300751000_34.178.250125.75","doi-asserted-by":"crossref","first-page":"17534666241271917","DOI":"10.1177\/17534666241271917","article-title":"Personalised indication of augmentation therapy for emphysema associated with severe alpha-1 antitrypsin deficiency: a case series","volume":"18","author":"Aljama","year":"2024","journal-title":"Ther Adv Respir Dis"},{"key":"2025111201300751000_34.178.250125.76","unstructured":"ClinicalTrials.gov . Phase III, efficacy and safety of \u201cKamada-AAT for inhalation\u201d (InnovAATe). Date last accessed: 17 January 2025. Date last updated: 4 September 2025. https:\/\/clinicaltrials.gov\/study\/NCT04204252"},{"key":"2025111201300751000_34.178.250125.77","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.ccm.2020.05.006","article-title":"Inhaled corticosteroids in chronic obstructive pulmonary disease: benefits and risks","volume":"41","author":"Mkorombindo","year":"2020","journal-title":"Clin Chest Med"},{"key":"2025111201300751000_34.178.250125.78","doi-asserted-by":"crossref","first-page":"177","DOI":"10.4103\/ijmr.IJMR_90_20","article-title":"Antifibrotic drugs for idiopathic pulmonary fibrosis: what we should know?","volume":"152","author":"Hadda","year":"2020","journal-title":"Indian J Med Res"},{"key":"2025111201300751000_34.178.250125.79","doi-asserted-by":"crossref","first-page":"e202002120","DOI":"10.1083\/jcb.202002120","article-title":"Telomerase treatment prevents lung profibrotic pathologies associated with physiological aging","volume":"219","author":"Pi\u00f1eiro-Hermida","year":"2020","journal-title":"J Cell Biol"},{"key":"2025111201300751000_34.178.250125.80","doi-asserted-by":"publisher","DOI":"10.1161\/ATVBAHA.108.175620"},{"key":"2025111201300751000_34.178.250125.81","doi-asserted-by":"publisher","DOI":"10.1038\/nm1358"}],"container-title":["European Respiratory Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/16000617.0125-2025","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:30:19Z","timestamp":1762939819000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/16000617.0125-2025"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":81,"journal-issue":{"issue":"178","published-online":{"date-parts":[[2025,11,12]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1183\/16000617.0125-2025"],"URL":"https:\/\/doi.org\/10.1183\/16000617.0125-2025","relation":{},"ISSN":["0905-9180","1600-0617"],"issn-type":[{"value":"0905-9180","type":"print"},{"value":"1600-0617","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}